Avanos Medical (AVNS) Debt to Equity (2016 - 2025)
Avanos Medical (AVNS) has disclosed Debt to Equity for 12 consecutive years, with $0.01 as the latest value for Q4 2025.
- Quarterly Debt to Equity rose 15.52% to $0.01 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.01 through Dec 2025, up 15.52% year-over-year, with the annual reading at $0.01 for FY2025, 15.52% up from the prior year.
- Debt to Equity hit $0.01 in Q4 2025 for Avanos Medical, up from $0.01 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.18 in Q4 2022 to a low of -$0.22 in Q2 2023.
- Historically, Debt to Equity has averaged -$0.0 across 5 years, with a median of $0.01 in 2023.
- Biggest YoY gain for Debt to Equity was 102.8% in 2024; the steepest drop was 2734.87% in 2024.
- Year by year, Debt to Equity stood at $0.1 in 2021, then skyrocketed by 75.99% to $0.18 in 2022, then plummeted by 96.14% to $0.01 in 2023, then skyrocketed by 63.1% to $0.01 in 2024, then rose by 15.52% to $0.01 in 2025.
- Business Quant data shows Debt to Equity for AVNS at $0.01 in Q4 2025, $0.01 in Q3 2025, and -$0.01 in Q2 2025.